4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-21-000405
President-Protein Sciences sold 27,159 shares at an average $504.00 ($13,688,193)
- President-Protein Sciences acquired 27,958 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Eansor Norman David · President-Protein Sciences
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-12 | Exercise or conversion : show line 1 in the form | +27,159 | $125.05 | $3,396,233 | 28,477 | D |
| 2021-11-12 | Sale : show line 2 in the form | −700 | $504.09 | $352,860 | 27,777 | D |
| 2021-11-12 | Sale : show line 3 in the form | −200 | $504.78 | $100,956 | 27,577 | D |
| 2021-11-12 | Sale : show line 4 in the form | −300 | $502.99 | $150,897 | 27,277 | D |
| 2021-11-12 | Sale : show line 5 in the form | −537 | $504.14 | $270,725 | 26,740 | D |
| 2021-11-12 | Sale : show line 6 in the form | −400 | $505.01 | $202,002 | 26,340 | D |
| 2021-11-12 | Sale : show line 7 in the form | −4,054 | $502.77 | $2,038,221 | 22,286 | D |
| 2021-11-12 | Sale : show line 8 in the form | −9,043 | $503.61 | $4,554,137 | 13,243 | D |
| Open-market sales · 27,159 sh · avg $504.00 · $13,688,193 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-12 | Exercise or conversion : show line 13 in the form Stock Options (Right to Buy) | −27,159 | 799 | D |
| 2021-11-16 | Exercise or conversion : show line 14 in the form Stock Options (Right to Buy) | −799 | 0 | D |
Loading xslF345X03/edgar.xml…